Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed |
|---|---|---|
|
Ibotta, Inc.
13G/A
Amendment 1
IBTA · 451051106
|
1.5% |
2/12/2026
Event 12/31/2025
|
|
Nextdoor Holdings, Inc.
13G/A
Amendment 1
NXDR · 65345M108
|
4.9% |
2/12/2026
Event 12/31/2025
|
|
Arcturus Therapeutics Holdings Inc.
13G/A
Amendment 2
ARCT · 03969T109
|
7.2% |
11/13/2025
Event 9/30/2025
|
|
Ibotta, Inc.
13G
IBTA · 451051106
|
5.1% |
11/13/2025
Event 9/30/2025
|
|
Nextdoor Holdings, Inc.
13G
NXDR · 65345M108
|
5.7% |
11/13/2025
Event 9/30/2025
|
|
10x Genomics, Inc.
13G/A
Amendment 1
TXG · 88025U109
|
4.7% |
11/13/2025
Event 9/30/2025
|
|
10x Genomics, Inc.
13G
TXG · 88025U109
|
5.4% |
8/13/2025
Event 6/30/2025
|
|
Arcturus Therapeutics Holdings Inc.
13G/A
Amendment 1
ARCT · 03969T109
|
7.1% |
5/12/2025
Event 3/31/2025
|
|
10x Genomics, Inc.
13G/A
Amendment 1
TXG · 88025U109
|
5.0%
Checked 5% or less
|
5/12/2025
Event 3/31/2025
|
|
Quantum-Si Inc
13G/A
Amendment 1
QSI · 74765K105
|
4.9% |
2/13/2025
Event 12/31/2024
|
|
Nextdoor Holdings, Inc.
13G/A
Amendment 1
NXDR · 65345M108
|
4.1% |
2/13/2025
Event 12/31/2024
|
|
Adaptive Biotechnologies Corp
13G/A
Amendment 1
ADPT · 00650F109
|
4.6% |
2/13/2025
Event 12/31/2024
|